EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma—diagnostic challenge and report of two cases

Hugo Carrillo-Ng iD, Yu Liang, Sue Chang, Michelle Afkhami, Thomas Gernon, Diana Bell, Javier A Arias-Stella iD

Genes, Chromosomes and Cancer · 2023

DOI: 10.1002/gcc.23145 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2023. Verfasst von Hugo Carrillo-Ng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, City of Hope National Medical Center, Duarte, California, USA. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Rhabdomyosarcoma, Embryonal, Carcinoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhabdomyosarcomas (RMS) are malignant mesenchymal tumors with skeletal muscle differentiation which are classified into alveolar, embryonal, pleomorphic, and spindle cell/sclerosing RMS. Within the spindle cell/sclerosing RMS tumor type there is a recently recognized sub‐type categorized as intraosseous spindle cell RMS with TFCP2 / NCOA2 gene fusion. This rare tumor is highly aggressive with predominant involvement of the craniofacial and pelvic bones with approximately 30 cases reported to date. Histopathologic features include spindle cell and epithelioid morphology with a characteristic co‐expression of epithelial markers, myogenic markers, and ALK1 expression. We report two cases of gnathic spindle cell/sclerosing RMS with FUS::TFCP2 gene fusion that were initially interpreted as carcinomas by referring institutions and later reclassified when encountered in our practice after additional work‐up and molecular characterization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyosarcomaRhabdomyosarcoma, EmbryonalCarcinomaAdultHumansChildGene FusionDNA-Binding ProteinsTranscription FactorsRNA-Binding Protein FUS

Stichwörter der Autor:innen

FUS::TFCP2 FusionIntraosseous spindle cell RMSRhabdomyosarcoma (RMS)Spindle cell/sclerosing RMSTFCP2

Substanzen

TFCP2 protein, humanDNA-Binding ProteinsTranscription FactorsFUS protein, humanRNA-Binding Protein FUS

Autor:innen und Institutionen

  • Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.
  • Department of Surgery, City of Hope National Medical Center, Duarte, California, USA.

ORCID-Profile: Hugo Carrillo-Ng, Javier A Arias-Stella

Zitieren

APA

Carrillo-Ng, H., Liang, Y., Chang, S., Afkhami, M., Gernon, T., Bell, D., & Arias-Stella, J. A. (2023). Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma—diagnostic challenge and report of two cases. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23145

Vancouver

Carrillo-Ng H, Liang Y, Chang S, Afkhami M, Gernon T, Bell D, et al. Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma—diagnostic challenge and report of two cases. Genes, Chromosomes and Cancer. 2023. doi:10.1002/gcc.23145

BibTeX
@article{CarrilloNg2023,
  author = {Carrillo-Ng, Hugo and Liang, Yu and Chang, Sue and Afkhami, Michelle and Gernon, Thomas and Bell, Diana and Arias-Stella, Javier A},
  title = {Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma—diagnostic challenge and report of two cases},
  journal = {Genes, Chromosomes and Cancer},
  year = {2023},
  doi = {10.1002/gcc.23145}
}
Kostenlos starten →